101 related articles for article (PubMed ID: 23589809)
1. Haemophilus influenzae type B in an immunocompetent, fully vaccinated ALL survivor.
Nevin J; Kanter Washko J; Arnold J
Pediatrics; 2013 May; 131(5):e1639-42. PubMed ID: 23589809
[TBL] [Abstract][Full Text] [Related]
2. Why the rise in Haemophilus influenzae type b infections?
Silfverdal SA; Bodin L; Olcén P
Lancet; 2003 Jul; 362(9380):331. PubMed ID: 12892974
[No Abstract] [Full Text] [Related]
3. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b.
Ek T; Mellander L; Hahn-Zoric M; Abrahamsson J
J Pediatr Hematol Oncol; 2004 Nov; 26(11):727-34. PubMed ID: 15543007
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
[TBL] [Abstract][Full Text] [Related]
5. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
9. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
10. [Antibody titer, immunologic memory and protective efficiency of the vaccine against Haemophilus influenzae type B. Vaccine Committee of the Spanish Association of Pediatrics].
An Esp Pediatr; 1999 Apr; 50(4):341-5. PubMed ID: 10356824
[No Abstract] [Full Text] [Related]
11. Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster.
Mallet E; Matisse N; Mathieu N; Langue J; Boisnard F; Soubeyrand B;
Vaccine; 2004 Mar; 22(11-12):1415-22. PubMed ID: 15063564
[TBL] [Abstract][Full Text] [Related]
12. The first reported case of possible Haemophilus influenzae type b vaccine failure from Kuwait and literature-review.
Purohit P; Al-Obaid IA; Omar NG
J Infect Public Health; 2014; 7(2):99-105. PubMed ID: 24216517
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey.
Yüksel N; Beyazova U; Balci IF; Aksakal FN; Camurdan AD; Sahin F; Rota S
Int J Infect Dis; 2012 May; 16(5):e354-7. PubMed ID: 22387144
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
15. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.
Goldblatt D; Richmond P; Millard E; Thornton C; Miller E
J Infect Dis; 1999 Aug; 180(2):538-41. PubMed ID: 10395878
[TBL] [Abstract][Full Text] [Related]
16. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia.
de de la Fuente Garcia I; Coïc L; Leclerc JM; Laverdière C; Rousseau C; Ovetchkine P; Tapiéro B
Pediatr Blood Cancer; 2017 Feb; 64(2):315-320. PubMed ID: 27718310
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae type b serology in childhood leukaemia: a case-control study.
Groves FD; Sinha D; Kayhty H; Goedert JJ; Levine PH
Br J Cancer; 2001 Aug; 85(3):337-40. PubMed ID: 11487261
[TBL] [Abstract][Full Text] [Related]
18. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
19. Imperfect memory and the development of Haemophilus influenzae type B disease.
Lucas AH; Granoff DM
Pediatr Infect Dis J; 2001 Mar; 20(3):235-9. PubMed ID: 11303822
[TBL] [Abstract][Full Text] [Related]
20. A comparative study to evaluate the safety and immunogenicity of two lots of Haemophilus influenzae type-B conjugate vaccine manufactured at different scales.
Hirve S; Bavdekar A; Juvekar S; Agarwal D; Barde P; Mangrule S; Patwardhan M; Pandit A; Kulkarni PS
Vaccine; 2011 Jul; 29(33):5363-7. PubMed ID: 21651947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]